Nixon, A. B., Navarro, F., Zhou, K. I., Abbott, C., Howard, L., Brady, J. C., … Uronis, H. E. (2024). Ultra-sensitive ctDNA dynamics to capture therapy response in pembrolizumab-treated gastroesophageal cancer. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Nixon, Andrew B., Fabio Navarro, Katherine I. Zhou, Charles Abbott, Lauren Howard, John C. Brady, Yingmiao Liu, et al. “Ultra-sensitive ctDNA dynamics to capture therapy response in pembrolizumab-treated gastroesophageal cancer.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Nixon AB, Navarro F, Zhou KI, Abbott C, Howard L, Brady JC, et al. Ultra-sensitive ctDNA dynamics to capture therapy response in pembrolizumab-treated gastroesophageal cancer. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Nixon, Andrew B., et al. “Ultra-sensitive ctDNA dynamics to capture therapy response in pembrolizumab-treated gastroesophageal cancer.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

Nixon AB, Navarro F, Zhou KI, Abbott C, Howard L, Brady JC, Liu Y, Jia J, Niedzwiecki D, Chen R, Strickler JH, Boyle SM, Uronis HE. Ultra-sensitive ctDNA dynamics to capture therapy response in pembrolizumab-treated gastroesophageal cancer. JOURNAL OF CLINICAL ONCOLOGY. 2024.